Why We're Watching These 2 Marijuana Penny Stocks Right Now

Money Morning Director of Technology & Venture Capital Research Michael A. Robinson sees four watershed events in the next 365 days that can send the prices of marijuana penny stocks skyrocketing.

marijuana penny stocks"The profit potential is enormous. And I want to make sure everyone has the chance to deploy their capital when these upcoming events come to pass," Robinson said on Sept. 14, 2017.

You can access Robinson's free marijuana prediction report right here.

And on top of Robinson's report, we are providing Money Morning readers with two pot penny stocks to watch today.

While these aren't recommendations, we're keeping an eye on these cannabis stocks ahead of the upcoming events Robinson says could send pot stocks soaring.

And the first marijuana company on our radar just completed its inaugural cannabis oil sale...

Watch These Two Marijuana Penny Stocks Heading into 2018

Future Farm Technologies Inc. (OTCMKTS: FFRMF) completed its first cannabis oil sale through its subsidiary, FFM Consulting Services LLC, according to a Sept. 14 MarijuanaStocks.com report

Details about the sale weren't provided, but large distributors are now requesting pricing for 2,500 kilos of cannabis oil per year from FFM, according to the same MarijuanaStocks.com report. We don't know how much Future Farm will charge, but we can make some projections.

Brilliant: Timing is everything when it comes to making money in markets - and this new, free service we created puts timing on your side...

CBDEssence.net sells CBD edible hemp oil for $59.99 per ounce. There are 88,184 ounces in 2,500 kilograms, so a company could net $5.2 million in revenue from 2,500 kilos being sold.

Again, we don't know how much Future Farm will sell its cannabis oil for. But we can project how much Future Farm could make from price markups from a range of industry prices.

According to SmallBusiness.Chron.com, the markup on baby food is around 8%, and cars are marked up between 5% and 10%. Even if CBD is marking up its oil 10% from the wholesale price, it still means FFRMF could generate $4.4 million in revenue.

Now, like most penny stocks, the FFRMF stock price has been volatile over the last 52 weeks. It's traded for a high of $0.75 and a low of $0.09 during that time. Today, FFRMF opened at $0.22.

But as more states legalize cannabis and as marijuana companies can sell more products, there's mainstream potential for pot stocks. And that means more profit for shareholders.

And the next pot stock we're watching could make the first cannabis prescription of its kind for cancer patients, while also lining the pockets of long-term shareholders...

Medical cannabis stocks, like GW Pharmaceuticals Plc. (Nasdaq ADR: GWPH), can climb quickly with regulatory approval. GW Pharmaceuticals skyrocketed 1,100% over the past four years, thanks in part to growing sales from one of its drugs that was fully approved for spasticity due to multiple sclerosis in Canada in 2010

BREAKING: New Legislation Could Turn Tiny Pot Stocks into Millions. Click Here...

Right now, the company is entering its medication into Phase 3 trials that could be the first type of cannabis medicine of its kind...

This Could Be the Best Medical Penny Pot Stock to Watch Right Now

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Tetra Bio-Pharm Inc. (OTCMKTS: TBPMF) announced on Sept. 18 it was filing a clinical trial application in the next few weeks for its PPP001 cannabis drug.

PPP001 is a dried cannabis pellet designed to be smoked by advanced cancer patients.

Now, because Tetra-Bio is based in Canada, it will first try to get its new medical marijuana drug approved in Canada. According to Tetra-Bio, this will be the first phase 3 clinical trial studying the therapeutic benefits of a smoked dried cannabis prescription drug in terminal cancer patients.

In the phase 3 trial, PPP001 will have to show it's a better treatment then standard treatments, according to the Canadian Cancer Society. Phase 4 will gather more information about possible risks and benefits that didn't show up in earlier testing.

Researchers will also continue to follow the results of participants who completed phase 3 trials.

If the trials show a new drug for cancer is safe and effective, it will then be submitted to Health Canada for approval. When it's approved, doctors can then recommend PPP001 to patients.

And as products become approved, marijuana stock prices can skyrocket.

For example, GW Pharmaceuticals traded for $9 per share on June 5, 2013. But as its mouth spray, Sativex, was approved for use in patients with multiple sclerosis in Canada, Australia, Spain, and the UK, and as its sales grew, the stock price skyrocketed to $109.26 per share.

That's a 1,114% gain in just four years.

Of course, there's no guarantee the TBPMF stock price will have similar returns. But as it opened at $0.59 today, there's still the potential to make massive profits.

As Canada is expected to completely legalize cannabis by July 1, 2018, even more companies could receive regulatory approval, and Robinson sees an opportunity to turn a small stake into a fortune.

Michael is our renowned pot stock expert and one of our most prominent and respected investing "gurus" here at Money Map Press - and for good reason.

He is one of the top financial analysts working today. Make no mistake: Michael's ideas are completely his own.

He's been a board member for a Silicon Valley venture capital firm and a senior advisor to 12 high-tech startups.

He's also a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style.

His research is world class, too. The Oakland TribuneDetroit NewsThe San Francisco ExaminerThe Kansas City TimesWealth Magazine, and American Banker have all published his reporting. He's even appeared on Larry King's syndicated radio show and is a regular guest on CNBC's "The Rundown" and FOX Business Network's "Cavuto: Coast to Coast."

We've already seen gains throughout the market as high as 516%, 523%, 416%, 436%, 293%, and 272% - just to name a few. But the recent news from our neighbors to the north could blow all that away. For all you need to know to profit from the upcoming total legalization of marijuana in Canada, click here.

Follow Money Morning on TwitterFacebook, and LinkedIn.